VTVT · vTv Therapeutics Inc.
$31.08
+0.06 (+0.19%)
At close · Jul 28
Market Cap
$122.42M
Shares
3.94M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Paul Sekhri | CEO | $6,638,252 |
| Michael Tung | CFO | $2,441,869 |
| Steven Tuch | CFO | $142,298 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Paul Sekhri | CEO | $3,863,827 |
| Steven Tuch | CFO | $1,520,277 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Paul Sekhri | CEO | $1,331,955 |
| Steven Tuch | CFO | $670,249 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Paul Sekhri | CEO | $1,721,433 |
| Deepa Prasad | CEO | $1,326,967 |
| Richard S. Nelson | Director | $514,071 |
| Steven Tuch | CFO | $379,866 |
| Barry Brown | Chief Accounting Officer | $367,456 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Deepa Prasad | CEO | $3,292,465 |
| Stephen L. Holcombe | CEO | $1,911,261 |
| Rudy C. Howard | CFO | $881,455 |
| Robin E. Abrams | Executive Chairperson | — |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Stephen L. Holcombe | CEO | $1,401,179 |
| Rudy C. Howard | CFO | $934,908 |
| Robin E. Abrams | Executive Chairperson | $599,093 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Stephen L. Holcombe | CEO | $832,803 |
| Rudy C. Howard | CFO | $591,379 |
| Robin E. Abrams | Executive Chairperson | $393,628 |
| Jeffrey B. Kindler | Chairman | $277,044 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Stephen L. Holcombe | CEO | $459,400 |
| Rudy C. Howard | CFO | $357,238 |
| Jeffrey B. Kindler | Chairman | $250,000 |